Quick answers
- What is Cartia XT?
- Cartia XT is a brand name of Diltiazem, a prescription medicine. The FDA NDC Directory lists 7 Cartia XT products in 4 strengths and forms.
- Who makes Cartia XT?
- Actavis Labs Fl Inc holds the FDA application for Cartia XT (ANDA074752, approved July 9, 1998). 2 other companies (repackagers or distributors) also list Cartia XT products.
- Is there a generic or store brand of Cartia XT?
- Yes. The FDA NDC Directory lists 127 other products with the same active ingredients, strength and form as a Cartia XT product, 123 of them generic. Ask your pharmacist whether one is right for you.
- What do pharmacies pay for Cartia XT?
- CMS lists a National Average Drug Acquisition Cost (NADAC) for 4 Cartia XT strengths and forms (see the table below). That is what pharmacies pay to buy it, not what you pay: your price depends on your insurance and your pharmacy.
- Has Cartia XT been recalled?
- FDA enforcement reports list 1 recall of Cartia XT products; the newest started October 27, 2021. A recall usually concerns specific lots, not every product.
What Cartia XT is
Each Cartia XT product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Diltiazem · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| diltiazem hydrochloride 120 mg capsule, extended release (oral) | Cartia XT | 45 products, 31 companies | DailyMed |
| diltiazem hydrochloride 180 mg capsule, extended release (oral) | Cartia XT | 33 products, 20 companies | DailyMed |
| diltiazem hydrochloride 240 mg capsule, extended release (oral) | Cartia XT | 31 products, 22 companies | — |
| diltiazem hydrochloride 300 mg capsule, extended release (oral) | Cartia Xt | 18 products, 13 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Diltiazem →
FDA approval
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| ANDA074752 | Actavis Labs Fl Inc | July 9, 1998 | 7 |
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| diltiazem hydrochloride 120 mg capsule, extended release | Generic: Cartia XT | $0.1458 per capsule Generic of the same strength and form: $0.1046–$1.94 per capsule |
| diltiazem hydrochloride 180 mg capsule, extended release | Generic: Cartia XT | $0.1860 per capsule Generic of the same strength and form: $0.1607–$0.3728 per capsule |
| diltiazem hydrochloride 240 mg capsule, extended release | Generic: Cartia XT | $0.2048 per capsule Generic of the same strength and form: $0.1469–$0.5048 per capsule |
| diltiazem hydrochloride 300 mg capsule, extended release | Generic: Cartia XT | $0.3041 per capsule Generic of the same strength and form: $0.2737–$0.3041 per capsule |
NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list Cartia XT
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Cartia XT products.
- Actavis Pharma, Inc.4 products
- Bryant Ranch Prepack2 products
- DirectRx1 product
Recalls
From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
October 27, 2021 · Class II · Terminated · D-0232-2022
Labelling: Incorrect Exp. Date
Cartia XT (Diltiazem Hydrochloride Extended-Release Capsules, USP) 120 mg, Rx Only, 90 capsules, labelled as (a) Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054; (b) Manufactured By: Actavis Laborat — Teva Pharmaceuticals USA
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.